Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS

K Thomas, J Eisele, FA Rodriguez-Leal… - Neuroimmunology & …, 2016 - AAN Enterprises
Objective: Alemtuzumab exerts its clinical efficacy by its specific pattern of depletion and
repopulation of different immune cells. Beyond long-term immunologic and clinical data, little …

[HTML][HTML] Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS

K Thomas, J Eisele, FA Rodriguez-Leal… - Neurology® …, 2016 - ncbi.nlm.nih.gov
Objective: Alemtuzumab exerts its clinical efficacy by its specific pattern of depletion and
repopulation of different immune cells. Beyond long-term immunologic and clinical data, little …

Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS

K Thomas, J Eisele… - Neurology (R) …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective Alemtuzumab exerts its clinical efficacy by its specific pattern of depletion and
repopulation of different immune cells. Beyond long-term immunologic and clinical data, little …

Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS.

K Thomas, J Eisele, FA Rodriguez-Leal… - Neurology (r) …, 2016 - europepmc.org
Objective Alemtuzumab exerts its clinical efficacy by its specific pattern of depletion and
repopulation of different immune cells. Beyond long-term immunologic and clinical data, little …

Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS.

K Thomas, J Eisele, FA Rodriguez-Leal… - Neurology (r) …, 2016 - europepmc.org
Objective Alemtuzumab exerts its clinical efficacy by its specific pattern of depletion and
repopulation of different immune cells. Beyond long-term immunologic and clinical data, little …